Immune Therapy Holdings (Sweden)
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis treatment for immune mediated inflammatory diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Immune Therapy Holdings (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
80%
Total
Publications
64
Total Open
Publications
51
Total
Citations
766
Open Access
Percentage
80%
Total
Publications
64
Total Open
Publications
51
Total
Citations
766
Breakdown
Publisher Open
33%
Both
41%
Other Platform Open
5%
Closed
21%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
15
Hybrid 32%
15
No Guarantees 36%
17
Other Platform Open
Domain 79%
23
Institution 41%
12
Other Internet 14%
4
Preprint 7%
2
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 23 |
University College of Arts Crafts and Design | Institution | 8 |
DOI | Other Internet | 4 |
Imperial College London | Institution | 2 |
Goethe University Frankfurt | Institution | 2 |
bioRxiv | Preprint | 2 |
University of Oslo | Institution | 1 |
University of Melbourne | Institution | 1 |
University of Liège | Institution | 1 |
University of Leicester | Institution | 1 |